Clinical Trials Directory

Trials / Completed

CompletedNCT03898284

Impulse Oscillometry for Prognostication in Idiopathic Pulmonary Fibrosis

Status
Completed
Phase
Study type
Observational
Enrollment
54 (actual)
Sponsor
University Hospital, Tours · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

A 5-point decline of forced vital capacity expressed as % predicted, over 6 months, is the current definition of disease progression (fast decline in lung function) in idiopathic pulmonary fibrosis. There is a need for techniques allowing to characterize disease progression earlier, so that treatment may be adapted as early as possible in the lack of a response. Hypothesis. Our hypothesis is that 3-month changes of lung function parameters measured by a novel technique, impulse oscillometry, predicts 6-month changes in forced vital capacity in idiopathic pulmonary fibrosis.

Detailed description

A 5-point decline of forced vital capacity expressed as % predicted, over 6 months, is the current definition of disease progression (fast decline in lung function) in idiopathic pulmonary fibrosis. There is a need for techniques allowing to characterize disease progression earlier, so that treatment may be adapted as early as possible in the lack of a response. Hypothesis. Our hypothesis is that 3-month changes of lung function parameters measured by a novel technique, impulse oscillometry, predicts 6-month changes in forced vital capacity in idiopathic pulmonary fibrosis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTImpulse OscillometryImpulse Oscillometry will be performed in addition to usual care

Timeline

Start date
2019-04-23
Primary completion
2021-09-27
Completion
2021-09-27
First posted
2019-04-01
Last updated
2021-11-11

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03898284. Inclusion in this directory is not an endorsement.